Overview Efficacy and Safety of SH T00660AA in Treatment of Endometriosis Status: Completed Trial end date: 2006-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis Phase: Phase 3 Details Lead Sponsor: Bayer